The roles of mitotic arrest and protein synthesis in induction of apoptosis and differentiation in neuroblastoma cells in culture

Developmental Brain Research

Volumn 105, Issue 2, 1998, Pages 175-180

  Smith, TaTanisha K ^a   Nylander, Karen D ^a   Schor, Nina Felice ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Antimitotic agent; Apoptosis; Neuroblastoma

Indexed keywords

VINBLASTINE; ZINOSTATIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; DNA CLEAVAGE; IMMEDIATE EARLY GENE; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SCHWANN CELL; TARGET CELL;

EID: 0032502058     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)00168-5     Document Type: Article

References (28)

1. Chen Y.R., Meyer C.F., Tan T.H. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem. 271:1996;631-634.
2. Cortazzo M., Schor N.F. Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2. Cancer Res. 56:1996;1199-1203.
3. Cummings M. Increased c-fos expression associated with hyperthermia-induced apoptosis of a Burkitt lymphoma cell line. Int. J. Radiat. Biol. 68:1995;687-692.
4. Estus S., Zaks W.J., Freeman R.S., Gruda M., Bravo R., Johnson E.M. Jr. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1994;1717-1727.
5. Falcione M., Milligan K.D., Schwartz M.C., Schor N.F. Prevention of neocarzinostatin-induced cell death and morphologic change in SK-N-SH human neuroblastoma cells by continuous exposure to nerve growth factor. Biochem. Pharmacol. 46:1993;731-738.
6. Freemerman A.J., Turner A.J., Birrer M.J., Szabo E., Valerie K., Grant S. Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. Mol. Pharmacol. 49:1996;788-795.
7. Freeman R.S., Estus S., Horigame K., Johnson E.M. Jr. Cell death genes in invertebrates and (maybe) vertebrates. Curr. Opin. Neurobiol. 3:1993;25-31.
8. Gajate C., Alonso M.T., Schimmang T., Mollinedo F. c-Fos is not essential for apoptosis. Biochem. Biophys. Res. Commun. 218:1996;267-272.
9. Goldstone S.D., Lavin M.F. Prolonged expression of c-jun and associated activity of the transcription factor AP-1, during apoptosis in a human leukaemic cell line. Oncogene. 9:1994;2305-2311.
10. Hartsell T.L., Yalowich J.C., Ritke M., Martinez A.J., Schor N.F. Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin. J. Pharmacol. Exp. Ther. 275:1995;479-485.
11. Hartsell T.L., Hinman L.M., Hamann P.R., Schor N.F. Determinants of the response of neuroblastoma cells to DNA damage: the roles of pretreatment cell morphology and chemical nature of the damage. J. Pharmacol. Exp. Ther. 277:1996;1158-1166.
12. Iseki S., Mori T. Effect of poly(adenosine diphosphate-ribose) polymerase inhibitors on neocarzinostatin-induced G2 delay in HeLa cells. Cancer Res. 45:1985;4224-4228.
13. Latinis K.M., Koretzky G.A. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood. 87:1996;871-875.
14. Melino G., Annicchiarico-Petruzzelli M., Piredda L., Candi E., Gentile V., Davies P.J.A., Piacentini M. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell Biol. 14:1994;6584-6596.
15. Milas L., Hunter N.R., Kurdoglu B., Mason K.A., Meyn R.E., Stephens L.C., Peters L.J. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35:1995;297-303.
16. Milross C.G., Mason K.A., Hunter N.R., Chung W.-K., Peters L.J., Milas L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J. Natl. Cancer Inst. 88:1996;1308-1313.
17. Pandey S., Wang E. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell Biochem. 58:1995;135-150.
18. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J.L., Melino G. Phenotype-specific 'tissue' transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer. 52:1992;271-278.
19. Preston G.A., Lyon T.T., Yin Y., Lang J.E., Solomon G., Annab L., Sribivasan D.G., Alcorta D.A., Barrett J.C. Induction of apoptosis by c-Fos protein. Mol. Cell. Biol. 16:1996;211-218.
20. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
21. Rampalli A.M., Zelenka P.S. Insulin regulates expression of c-fos and c-jun and suppresses apoptosis of lens epithelial cells. Cell Growth Differ. 6:1995;945-953.
22. Sato N., Hotta K., Waguri S., Nitatori T., Tohyama K., Tsujimoto Y., Uchiyama Y. Neuronal differentiation of PC12 cells as a result of prevention of cell death by bcl-2. J. Neurobiol. 25:1994;1227-1234.
23. Schor N.F. Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture. J. Pharmacol. Exp. Ther. 249:1989;906-910.
24. N.F. Schor, The enediynes, In: B.A. Teicher (Ed.), Cancer Therapeutics: Experimental and Clinical Agents, Humana Press, Totowa, 1997, pp. 229-240.
25. Sherwood S.W., Sheridan J.P., Schimke R.T. Induction of apoptosis by the anti-tubulin drug colcemid: relationship of mitotic checkpoint control to the induction of apoptosis in HeLa S3 cells. Exp. Cell Res. 215:1994;373-379.
26. Vaux D.L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA. 90:1993;786-789.
27. Wilson L., Bamburg J.R., Mizel S.B., Grisham L.M., Creswell K.M. Interaction of drugs with microtubule proteins. Fed. Proc. 33:1974;158-166.
28. Xu Y.-J., Li D.-D., Zhen Y.-S. Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells. Cancer Chemother. Pharmacol. 27:1990;41-46.